news
A preclinical candidate calcitonin gene-related peptide (CGRP) antagonist has been…
18 May 2017 | By Sarah Wills (Drug Target Review)
A preclinical candidate calcitonin gene-related peptide (CGRP) antagonist has been nominated for advancement into further preclinical studies as an investigational treatment for migraine.